{"id":"W2970398865","doi":"10.1038/s41375-019-0554-1","title":"Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study","year":2019,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"F. Hoffmann-La Roche; Roche","keywords":"Fludarabine; Medicine; Obinutuzumab; Cyclophosphamide; Internal medicine; Chronic lymphocytic leukemia; Neutropenia; Tolerability; Gastroenterology; Clinical endpoint; Surgery; Oncology; Adverse effect; Leukemia; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004780873,0.000485099,0.001401714,0.0006016233,0.00008729802,0.00003745111,0.0005113622,0.0002422725,0.0002087709],"category_scores_gemma":[0.0001290928,0.0003126119,0.0002272725,0.003439671,0.0003020841,0.0001726956,0.0004208381,0.0005282753,0.00004427813],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.2762063,"about_ca_system_score_gemma":0.04516902,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0583939,"about_ca_topic_score_gemma":0.01175515,"domain_scores_codex":[0.9958848,0.0001927806,0.0008343917,0.000934714,0.001294272,0.00085906],"domain_scores_gemma":[0.9972147,0.0002971339,0.0003171554,0.001672243,0.0002504739,0.000248231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002800881,0.0001491659,0.957304,0.0007326385,0.002311222,0.0001972219,0.002673435,0.03208059,0.000126835,0.0000266412,0.00008668143,0.001510701],"study_design_scores_gemma":[0.08110272,0.002066713,0.7826284,0.0005064802,0.002274845,0.00004228914,0.0003057224,0.1303328,0.0002489246,0.00001028127,0.0001112452,0.0003695991],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946969,0.0008510995,0.000003578341,0.00002679464,0.00007764058,0.003662423,0.00002468191,0.00005724599,0.0005996251],"genre_scores_gemma":[0.996627,0.00009991843,0.00003325204,0.0001156517,0.00004430941,0.0001220507,0.00005730823,0.00007310231,0.002827451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2310373,"threshold_uncertainty_score":0.9999326,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008137454278293835,"score_gpt":0.2441764220748079,"score_spread":0.2360389677965141,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}